Information Provided By:
Fly News Breaks for June 3, 2019
TECH
Jun 3, 2019 | 08:28 EDT
Baird analyst Catherine Ramsey Schulte designated Bio-Techne as a Fresh Pick following its update for the Prostate Cancer Early Detection guidelines, with the discussion section including positive positioning for EPI. She said she would be adding to positions ahead of expected Medicare progress in June. Ramsey Schulte reiterated her Outperform rating and $222 price target on Bio-Techne shares.